Cargando…
Could upfront temozolomide chemotherapy postpone the need for radiotherapy in young patients with high-risk low-grade gliomas?
Autores principales: | Li, Ze-Yang, Yuan, Shi-Wen, Song, Yan-Yan, Hameed, N.U. Farrukh, Chen, Hong, Zhuang, Dong-Xiao, Lu, Jun-Feng, Gong, Fang-Yuan, Aibaidula, Abudumijit, Shi, Zhi-Feng, Wu, Shuai, Guo, Qi-Hao, Wu, Jin-Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183738/ https://www.ncbi.nlm.nih.gov/pubmed/33788781 http://dx.doi.org/10.1097/CM9.0000000000001434 |
Ejemplares similares
-
Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013) -
Could the Anti-Chaperone VER155008 Replace Temozolomide for Glioma Treatment
por: Shervington, Leroy, et al.
Publicado: (2015) -
Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment
por: Peng, Yuan, et al.
Publicado: (2018) -
An observation: Could the spread of Adenovirus in South Asia pose a hazard to global public health?
por: Ahamed, Rayhan, et al.
Publicado: (2023) -
Silver nanoparticles enhance the sensitivity of temozolomide on human glioma cells
por: Liang, Ping, et al.
Publicado: (2016)